Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignancies-Reference-Cited by-同舟云学术

Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignancies

Published:2008-11 Issue:3 Volume:376 Page:605-610
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Inohara Hidenori,Segawa Tatsuya,Miyauchi Akira,Yoshii Tadashi,Nakahara Susumu,Raz Avraham,Maeda Masahiro,Miyoshi Eiji,Kinoshita Noriaki,Yoshida Hiroshi,Furukawa Masashi,Takenaka Yukinori,Takamura Yuki,Ito Yasuhiro,Taniguchi Naoyuki

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference18 articles.

1. Galectins: structure and function of a large family of animal lectins;Barondes;J. Biol. Chem.,1994

2. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms;Inohara;Cancer,1999

3. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions;Bartolazzi;Lancet,2001

4. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon;Schoeppner;Cancer,1995

5. Fine needle aspiration biopsy of the thyroid: an appraisal;Gharib;Ann. Intern. Med.,1993

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology;Expert Review of Proteomics;2023-11-29

2. Decreased circulating levels of angiopoietin – 1 (Ang-1) are associated with the presence of multinodular goiter or differentiated thyroid cancer;Surgery in Practice and Science;2023-06

3. Decreased circulating levels of angiopoietin – 1 (Ang-1) are associated with the presence of benign or malignant thyroid disease.;2022-11-07

4. Galectin-9 as a biomarker of disease severity;Cellular Immunology;2021-03

5. Beyond immunohistochemistry and immunocytochemistry: a current perspective on galectin-3 and thyroid cancer;Expert Review of Anticancer Therapy;2019-11-22